Viewing nowCombinationBakoldi Tablet
Bazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
DaeHwa Pharmaceutical Co., Ltd.

MFDS item code 201803494 · Approved 2018.08.28 · Insurance code 645604960
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used to treat and prevent osteoporosis in postmenopausal women. It is particularly effective in reducing the occurrence of spinal fractures. However, its effectiveness for non-spinal fractures has not been firmly established. Therefore, taking this drug can improve spinal health and reduce fracture risks.
For patients requiring bazedoxifene whose vitamin D intake is insufficient. Take 1 tablet once daily, regardless of meals. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment; administer with caution. Patients with hepatic impairment: Administration is not recommended because the safety and efficacy of this medicine have not been established in patients with hepatic impairment.
This medication may increase the risk of thrombus formation in blood vessels, such as venous thromboembolism, so it is advisable not to use it in women at high risk for thrombosis. Caution is particularly needed in cases with risk factors like old age, obesity, prolonged immobility, recovery after surgery, trauma, or cancer. This medication is only approved for use in postmenopausal women and should not be taken by premenopausal women or women who may become pregnant. While it does not induce endometrial hyperplasia, if uterine bleeding occurs during treatment, it is essential to seek medical attention from a specialist. Its safety has not been established in breast cancer patients, and it is not recommended for prevention or treatment. It should also not be administered to individuals allergic to this drug or its components, those with a history of thrombosis, pregnant or breastfeeding women, patients with unexplained uterine bleeding, or those with symptoms of endometrial cancer. Additionally, patients with lactose intolerance, hypercalcemia, or kidney stones should avoid use. Patients with hypertriglyceridemia, kidney or liver disorders, restricted mobility, or those taking specific medications should use this medication cautiously, following a physician's directions. This drug may cause drowsiness or visual disturbances; therefore, caution is advised when driving or operating machinery. It is recommended to take supplements if calcium intake is insufficient, and additional supplementation may be necessary for patients at high risk of vitamin D deficiency. There is no specific antidote for overdose, so treatment should be based on symptoms, and blood calcium levels and renal function should be monitored regularly. Keep this medication out of the reach of children, and store it in its original container to prevent degradation in quality and misuse.
Venous thromboembolism, deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, hypersensitivity, drowsiness, flushing, leg cramps, dry mouth, urticaria, rash, itching, muscle cramps, peripheral edema, increased triglycerides, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased vision, blurred vision, photophobia, visual field defect, visual impairment, dry eye syndrome, eyelid edema, eyelid spasms, eye pain, eye swelling, abdominal pain, death, fever, generalized edema, fatigue, fractures, myalgia, shoulder rotator cuff syndrome, spinal canal stenosis, cerebral infarction, cerebral hemorrhage, bradycardia, respiratory failure, biliary stones, vomiting, gastritis, colonic polyps, belching, allergic reaction, chest discomfort, leg pain, edema, facial swelling, altered temperature sensation, lethargy, weakness, inadequate effect, dermatitis, localized skin reaction, increased sweating, eczema, hair loss, low back pain, arthralgia, muscle weakness, headache, pharyngitis, pyelonephritis, palpitations, bronchial disease, cough, asthma, shortness of breath, laryngitis, increased alkaline phosphatase, liver cysts, hepatocyte damage, weight gain, hyperlipidemia, central obesity, dysuria, abnormal urination, renal cysts, urinary incontinence, vaginal bleeding, breast engorgement, insomnia, leukocytosis, laceration, bruise, dyspepsia, nausea, constipation, diarrhea, psychological symptoms, altered consciousness, headache, nausea, loss of appetite, weight loss, increased thirst, arrhythmia, increased frequency of urination, kidney stones, renal calcification, calcification in the outer tissue of bones, myalgia, arthralgia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain the storage temperature between 1°C and 30°C at room temperature.
Yellow, bilaterally convex, rectangular film-coated tablet
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
DaeHwa Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hyouns Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.